E. Grasset

2.0k total citations · 1 hit paper
37 papers, 1.4k citations indexed

About

E. Grasset is a scholar working on Molecular Biology, Genetics and Pharmacology. According to data from OpenAlex, E. Grasset has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Pharmacology. Recurrent topics in E. Grasset's work include Venomous Animal Envenomation and Studies (5 papers), Gut microbiota and health (5 papers) and Gastrointestinal motility and disorders (4 papers). E. Grasset is often cited by papers focused on Venomous Animal Envenomation and Studies (5 papers), Gut microbiota and health (5 papers) and Gastrointestinal motility and disorders (4 papers). E. Grasset collaborates with scholars based in France, Switzerland and United States. E. Grasset's co-authors include M. Pinto, A Zweibaum, E Dussaulx, J F Desjeux, Rémy Burcelin, Louise Mannerås Holm, Fredrik Bäckhed, Louise E. Olofsson, Filipe De Vadder and Andrew J. Macpherson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Clinical Nutrition and Cell Metabolism.

In The Last Decade

E. Grasset

31 papers receiving 1.3k citations

Hit Papers

Gut microbiota regulates maturation of the adult enteric ... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Grasset France 13 691 371 229 204 147 37 1.4k
Ali Banan United States 18 903 1.3× 354 1.0× 221 1.0× 153 0.8× 207 1.4× 31 2.0k
Pierre de Coppet France 21 1.1k 1.5× 448 1.2× 261 1.1× 272 1.3× 247 1.7× 25 2.0k
José Emilio Mesonero Spain 23 539 0.8× 237 0.6× 238 1.0× 220 1.1× 218 1.5× 71 1.4k
Ana Isabel Alcalde Spain 20 431 0.6× 165 0.4× 166 0.7× 243 1.2× 99 0.7× 49 915
Edward S. Kimball United States 20 539 0.8× 211 0.6× 156 0.7× 116 0.6× 65 0.4× 66 1.8k
Thomas U. Greiner Sweden 15 1.1k 1.6× 566 1.5× 455 2.0× 157 0.8× 130 0.9× 25 1.8k
Kanako Hirano Japan 11 1.3k 1.9× 857 2.3× 182 0.8× 109 0.5× 252 1.7× 11 1.9k
David H. Barkla Australia 23 695 1.0× 204 0.5× 195 0.9× 94 0.5× 152 1.0× 64 1.8k
Robert Ducroc France 27 654 0.9× 513 1.4× 573 2.5× 119 0.6× 352 2.4× 63 2.2k
Frédéric Raymond Switzerland 20 1.2k 1.7× 878 2.4× 247 1.1× 143 0.7× 262 1.8× 33 2.1k

Countries citing papers authored by E. Grasset

Since Specialization
Citations

This map shows the geographic impact of E. Grasset's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Grasset with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Grasset more than expected).

Fields of papers citing papers by E. Grasset

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Grasset. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Grasset. The network helps show where E. Grasset may publish in the future.

Co-authorship network of co-authors of E. Grasset

This figure shows the co-authorship network connecting the top 25 collaborators of E. Grasset. A scholar is included among the top collaborators of E. Grasset based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Grasset. E. Grasset is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Briand, François, Caroline Dubroca, Guillaume Wettstein, et al.. (2025). Lanifibranor and semaglutide demonstrate multiple metabolic benefits in free-choice diet induced obese hamster models of MASH and MetALD. European Journal of Pharmacology. 1003. 177945–177945.
2.
Grasset, E., François Briand, Christiane Schön, et al.. (2024). A Specific Collagen Hydrolysate Improves Postprandial Glucose Tolerance in Normoglycemic and Prediabetic Mice and in a First Proof of Concept Study in Healthy, Normoglycemic and Prediabetic Humans. Food Science & Nutrition. 12(11). 9607–9620. 1 indexed citations
3.
Grasset, E., Anthony Puel, J. Charpentier, et al.. (2021). Gut microbiota dysbiosis of type 2 diabetic mice impairs the intestinal daily rhythms of GLP-1 sensitivity. Acta Diabetologica. 59(2). 243–258. 9 indexed citations
4.
Charpentier, J., François Briand, Benjamin Lelouvier, et al.. (2021). Liraglutide targets the gut microbiota and the intestinal immune system to regulate insulin secretion. Acta Diabetologica. 58(7). 881–897. 30 indexed citations
5.
Grasset, E. & Rémy Burcelin. (2019). The gut microbiota to the brain axis in the metabolic control. Reviews in Endocrine and Metabolic Disorders. 20(4). 427–438. 44 indexed citations
6.
Canceill, Thibault, Pascale Loubières, Jeffrey E. Christensen, et al.. (2018). Oral health and microbiota status in professional rugby players: A case-control study. Journal of Dentistry. 79. 53–60. 29 indexed citations
7.
Grasset, E., Anthony Puel, J. Charpentier, et al.. (2017). A Specific Gut Microbiota Dysbiosis of Type 2 Diabetic Mice Induces GLP-1 Resistance through an Enteric NO-Dependent and Gut-Brain Axis Mechanism. Cell Metabolism. 25(5). 1075–1090.e5. 229 indexed citations
8.
Martin, Daniel, E. Grasset, François A. Lemonnier, et al.. (2002). Efficacy of Humalog® injections before an afternoon meal and their acceptance by children and adolescents with Type 1 diabetes. Diabetic Medicine. 19(12). 1026–1031. 11 indexed citations
9.
Heshka, Stanley, et al.. (1994). Reduced risk of liver-function-test abnormalities and new gallstone formation with weight loss on 3350-kJ (800-kcal) formula diets. American Journal of Clinical Nutrition. 60(2). 249–254. 25 indexed citations
10.
Darmaun, Dominique, B. Just, Bernard Messing, et al.. (1994). Glutamine metabolism in healthy adult men: response to enteral and intravenous feeding. American Journal of Clinical Nutrition. 59(6). 1395–1402. 33 indexed citations
11.
Grasset, E., M. de Montalembert, Didier Chevenne, et al.. (1992). [Research of factors for glucose intolerance in mucoviscidosis].. PubMed. 49(1). 17–22. 10 indexed citations
12.
Aigrain, Y., et al.. (1992). Postobstructive enteropathy in infants with transient enterostomy: Its consequences on the upper small intestinal functions. Journal of Pediatric Surgery. 27(11). 1427–1432. 3 indexed citations
13.
Cézard, Jean‐Pierre, C Marche, J. Macry, et al.. (1991). Effects of dietary whey proteins, their peptides or amino-acids on the ileal mucosa of normally fed and starved rats. Clinical Nutrition. 10(1). 49–54. 23 indexed citations
14.
Grasset, E.. (1991). Protéines du lait et nutrition des différentes catégories de population. Le Lait. 71(2). 181–189. 1 indexed citations
15.
Rouyer‐Fessard, Christiane, Chantal Augeron, E. Grasset, et al.. (1989). VIP receptors and control of short circuit current in the human intestinal clonal cell line Cl.19A. Cellular and Molecular Life Sciences. 45(11-12). 1102–1105. 13 indexed citations
16.
Grasset, E., et al.. (1955). [Methods of L form transformations in Proteus vulgaris and Enterobacteriacea in vivo under the effect of penicillin].. PubMed. 88(5). 651–6. 2 indexed citations
17.
Grasset, E. & D. E. Schwartz. (1955). IN VIVO AND IN VITRO COMPARATIVE ASSAYS OF THE ANTICOAGULANT ACTIVITY OF DEXTRAN SULPHATE AND HEPARIN. British Journal of Pharmacology and Chemotherapy. 10(3). 317–320. 5 indexed citations
18.
Grasset, E., et al.. (1955). [Obtaining L-forms in Klebsiella pneumoniae in liquid surrounding in a mouse under the action of penicillin].. PubMed. 18(5). 1074–86. 1 indexed citations
19.
Grasset, E., et al.. (1955). [Fractioning by paper electrophoresis of Vipera russelli venom; properties and determination of coagulant and anticoagulant factors of this venom].. PubMed. 88(3). 271–81. 2 indexed citations
20.
Fabre, Roxane, et al.. (1951). [Relative importance of blood and lymphatic pathways for the absorption of medicinal and toxic substances. VII. Phenobarbital].. PubMed. 9(2). 98–103. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026